Orbimed Advisors LLC Wave Life Sciences Ltd. Transaction History
Orbimed Advisors LLC
- $3.21 Billion
- Q1 2025
A detailed history of Orbimed Advisors LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Orbimed Advisors LLC holds 180,000 shares of WVE stock, worth $1.2 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
180,000Holding current value
$1.2 Million% of portfolio
0.11%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding WVE
# of Institutions
205Shares Held
125MCall Options Held
499KPut Options Held
180K-
Ra Capital Management, L.P. Boston, MA18.2MShares$121 Million3.05% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12.5MShares$83.5 Million0.2% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$55.1 Million1.31% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$44.9 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.36MShares$42.4 Million0.56% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $579M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...